Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Share Price
Equities
GENIL
TREGENL00024
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
56.8 TRY | -1.65% | -4.22% | +21.05% |
Sales 2022 | 5.45B 168M 14.03B | Sales 2023 | 8.15B 252M 21B | Capitalization | 14.06B 434M 36.23B |
---|---|---|---|---|---|
Net income 2022 | 1.08B 33.36M 2.78B | Net income 2023 | 455M 14.06M 1.17B | EV / Sales 2022 | 2.76 x |
Net cash position 2022 | 494M 15.27M 1.27B | Net Debt 2023 | 594M 18.35M 1.53B | EV / Sales 2023 | 1.8 x |
P/E ratio 2022 |
14.4
x | P/E ratio 2023 |
30.9
x | Employees | 622 |
Yield 2022 |
2.15% | Yield 2023 |
-
| Free-Float | 25.75% |
1 day | -1.73% | ||
1 week | -4.22% | ||
Current month | -15.17% | ||
1 month | -15.17% | ||
3 months | +7.79% | ||
6 months | -6.89% | ||
Current year | +21.05% |
Managers | Title | Age | Since |
---|---|---|---|
Nadir Ulu
CTO | Chief Tech/Sci/R&D Officer | - | 01/23/01 |
Ali Ketencioglu
IRC | Investor Relations Contact | - | 01/21/01 |
Sales & Marketing | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Abidin Gulmus
CHM | Chairman | - | - |
Sukru Turkmen
BRD | Director/Board Member | - | - |
Ömer Dinçer
BRD | Director/Board Member | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.67% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 56.8 | -1.65% | 1 255 152 |
26/24/26 | 57.75 | +0.43% | 966,063 |
25/24/25 | 57.5 | +0.26% | 787,715 |
24/24/24 | 57.35 | -3.21% | 1,538,479 |
22/24/22 | 59.25 | +1.11% | 1,632,512 |
Delayed Quote Borsa Istanbul, April 29, 2024 at 07:36 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+21.05% | 534M | |
+26.51% | 661B | |
+27.27% | 566B | |
-6.35% | 352B | |
+20.40% | 332B | |
+3.37% | 283B | |
+14.36% | 231B | |
+5.22% | 200B | |
-9.00% | 195B | |
-4.77% | 145B |
- Stock Market
- Equities
- GENIL Stock